GlassScriptPhysician profile
Trevor M Soergel
NPI 1649267725
$7,457.49
in general payments reported to CMS, 2019-2025
42 companies · $1,622 in 2025
The $1,622 reported for 2025 was more than what 75% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,134 · 2020: $428 · 2021: $726 · 2022: $1,154 · 2023: $1,065 · 2024: $1,328 · 2025: $1,622.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,015.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,015.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,359.23 | 2021-2025 | Interstim, Altaviva |
| Medtronic USA, INC. | $525.86 | 2019-2020 | |
| Astellas Pharma US INC | $442.25 | 2019-2023 | Myrbetriq |
| Abbvie INC. | $320.14 | 2019-2024 | Botox |
| Urogen Pharma, INC. | $302.06 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $300.93 | 2023-2025 | Orgovyx, Gemtesa |
| Histosonics, INC. | $270.00 | 2025 | |
| Boston Scientific Corporation | $267.05 | 2019-2024 | Lithovue |
| Procept Biorobotics Corporation | $218.41 | 2021-2024 | Aquabeam System, Aquabeam Robotic System |
| Palette Life Sciences, INC. | $173.25 | 2022 | |
| Teleflex LLC | $172.11 | 2023-2024 | Urolift |
| Endo Pharmaceuticals INC. | $168.10 | 2019-2024 | Xiaflex |
| Accord Healthcare, INC. | $159.49 | 2022-2025 | |
| Calyxo, INC. | $158.78 | 2022-2025 | Cvac Aspiration System |
| Axonics, INC. | $151.07 | 2021-2022 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $143.54 | 2024 | 1788 |
| Sanara Medtech INC. | $127.27 | 2025 | Celleraterx |
| Novartis Pharmaceuticals Corporation | $125.17 | 2020-2025 | |
| Blue Earth Diagnostics | $121.72 | 2019 | |
| Progenics Pharmaceuticals, INC. | $111.14 | 2022-2023 | Pylarify |
| Myriad Genetic Laboratories, INC. | $101.25 | 2024 | Prolaris |
| Verity Pharmaceuticals INC. | $94.76 | 2024-2025 | Trelstar |
| C. R. Bard, INC. & Subsidiaries | $76.96 | 2021 | |
| Antares Pharma, INC. | $72.73 | 2019-2024 | Xyosted |
| Healthtronics Stone Solutions, LLC | $63.18 | 2025 | Dornier Medtech, Dornier Medtech, Cvac Aspiration System |
| Janssen Biotech, INC. | $51.80 | 2019-2024 | Erleada |
| Myovant Sciences INC. | $49.11 | 2022 | |
| Tolmar, INC. | $48.23 | 2024-2025 | Eligard |
| Amgen INC. | $40.99 | 2019 | |
| Rochester Medical Corporation | $29.17 | 2020 | |
| Halozyme INC | $28.72 | 2023 | |
| Allergan, INC. | $25.67 | 2020 | |
| Agiliti Surgical, INC. | $24.86 | 2025 | Boston Scientific Lumenis Pulse 120h Holmium Laser W/ Moses Technology |
| Eisai INC. | $23.41 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.73 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $19.36 | 2022 | |
| Innovation Technologies INC | $17.56 | 2024 | Irrisept |
| Ferring Pharmaceuticals INC. | $15.86 | 2019 | |
| Pfizer INC. | $12.38 | 2019 | |
| Coloplast Corp | $12.09 | 2019 | |
| Zyla Life Sciences, INC. | $11.10 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$9,770.18 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Trevor Soergel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.